Apparatus and method for detecting abnormal cardiac rhythms using an ultrasound sensor in an arrhythmia control system

• US 5,183,040 A
• Filed: 03/08/1991
• Issued: 02/02/1993
• Est. Priority Date: 03/08/1991
• Status: Expired due to Term

• Current Assignee: Pacesetter Incorporated (Abbott Laboratories)
• Original Assignee: Telectronics Pacing Systems, Inc (Abbott Laboratories)
• Inventors: Valenta, Harry L. Jr., Nappholz, Tibor A., Koestner, Ken
• Primary Examiner(s): Jaworski, Francis
• Assistant Examiner(s): MANUEL, GEORGE C
• Application Number:
  US07/665,842
• Time in Patent Office: 697 Days
• Field of Search: 128/419 D, 128/419 PG, 128/661.07, 128/661.08, 128/661.09, 128/661.10, 128/662.05, 128/661.04, 128/660.03
• US Class Current: 607/4
• CPC Class Codes: A61B 8/06 Measuring blood flow measuring volume flow in general G01F, e.g. G01F1/66, G01F1/72; measuring speed of fluids in general G01P5/00
• CPC Class Codes: A61B 8/12 in body cavities or body tracts, e.g. by using catheters catheters per se A61M25/00
• CPC Class Codes: A61B 8/445 Details of catheter construction
• CPC Class Codes: A61N 1/3622 comprising two or more electrodes co-operating with different heart regions
• CPC Class Codes: A61N 1/36528 the parameter being measured by means of ultrasound

Abstract

An antitachycardia pacer and pacing method automatically monitors and supports a patient'"'"'s hemodynamic status by measuring cardiac output using an ultrasonic sensor. By analyzing cardiac output, the pacer determines whether the heart is beating normally or under conditions of exercise, bradycardia, tachycardia, or fibrillation. If the heart is functioning normally or in bradycardia or exercise, the pacer supports the patient'"'"'s hemodynamic status by electrically stimulating the heart. The pacer analyzes cardiac output information, detects and classifies abnormal rhythms of tachycardia and fibrillation on the basis of this analysis, and initiates an appropriate therapy accordingly.

Claims

1. An antiarrhythmia pacing device for the reversion of cardiac arrhythmias comprising:

means for generating stimulation pulses and adapted to deliver said pulses to a patient'"'"'s heart,

ultrasonic means adapted to be implanted within the patient'"'"'s cardiovascular system for monitoring a cardiac output parameter corresponding to the volume of blood flow per unit of time within the cardiovascular system,

means for deriving a cardiac output standard based on a time history of said cardiac output parameter,

means for comparing said cardiac output parameter to said cardiac output standard,

means responsive to said comparing means for detecting and classifying a pathological cardiac arrhythmia when said cardiac output parameter is less than at least one predetermined percentage of said cardiac output standard, and

means responsive to said detecting means for controlling said generating means to operate in an antiarrhythmia pacing mode corresponding to said classification.

2. An antiarrhythmia pacing device according to claim 1, wherein said detecting means detects and classifies a pathological tachycardia condition and said controlling means controls said generating means to operate in an antitachycardia pacing mode.

3. An antiarrhythmia pacing device according to claim 1 in combination with an implantable pacemaker cardioverter/defibrillator device, wherein said classifying means classifies an arrhythmia as fibrillation when said cardiac output parameter is less than a second predetermined percentage of said cardiac output standard, said second predetermined percentage being lower than said one predetermined percentage, and wherein said detecting means issues a defibrillation signal to said controlling means upon detection of said fibrillation.

4. An antiarrhythmia pacing device according to claim 3, wherein said ultrasonic means is adapted to be implanted within the patient'"'"'s right heart for ensonifying the patient'"'"'s ascending aorta with ultrasonic energy and detecting returning ultrasonic energy reflected from blood cells within the ascending aorta.

5. An antiarrhythmia pacing device according to claim 1, wherein said ultrasonic means includes an ultrasonic transmitting means utilizing timed bursts of ultrasonic pulses, and an ultrasonic receiving means employing Doppler measurement techniques, for monitoring said parameter.

6. A dual chamber antitachycardia pacing device for the reversion of tachycardias comprising:

means for generating atrial and ventricular stimulation pulses and adapted to deliver said pulses to a patient'"'"'s atrium and ventricle, respectively,

ultrasonic means adapted to be implanted within the patient'"'"'s cardiovascular system for monitoring a cardiac output parameter corresponding to the volume of blood flow per unit of time within the cardiovascular system,

means for deriving a cardiac output standard based on a time history of said cardiac output parameter,

means for determining the patient'"'"'s heart rate,

analyzing means for comparing said cardiac output parameter to said cardiac output standard and for comparing said heart rate to a predetermined heart rate boundary,

means responsive to the detection of a pathological tachycardia by said analyzing means for detecting a pathological tachycardia when said cardiac output parameter is less than a predetermined percentage of said cardiac output standard and said heart rate is faster than said predetermined heart rate boundary, and

means responsive to the detection of a pathological tachycardia by said detecting means for controlling said generating means to operate in an antitachycardia pacing mode.

7. A dual chamber antitachycardia pacing device according to claim 6, further comprising:

means for operating in a dual chamber bradycardia pacing mode, having an interval between atrial heartbeats and ventricular stimulation pulses, when the patient'"'"'s heart is functioning with a below-normal natural rhythm,

means for initiating an A-V delay test operating submode of said dual chamber bradycardia pacing mode,

means responsive to the initiation of said A-V delay test operating submode for modulating the A-V delay between separate cardiac cycles,

means for associating respective ones of said monitored cardiac output parameters with their corresponding operating submode A-V delay values,

means responsive to said associating means for selecting an A-V delay associated with one of the largest cardiac output parameters, and

means for terminating said A-V delay test operating submode and resuming operation in said dual chamber bradycardia pacing mode utilizing said selected A-V delay as the interval between atrial heartbeats and ventricular stimulation pulses.

8. A dual chamber antitachycardia pacing device according to claim 7, wherein, in said antitachycardia pacing mode, atrial and ventricular pacing pulses are generated and delivered in a series of pulse trains with each train consisting of a plurality of pacing pulses and with said ventricular and atrial pacing pulses being delivered in an alternating sequence to the ventricle and to the atrium, respectively.

9. A dual chamber antitachycardia pacing device according to claim 8, wherein said atrial and ventricular pulses being delivered in said alternating sequence are spaced apart by said selected A-V delay interval.

10. A dual chamber antitachycardia pacing device according to claim 6, wherein, in said antitachycardia pacing mode, atrial and ventricular pacing pulses are generated and delivered in a series of pulse trains with each train consisting of a plurality of pacing pulses and with said ventricular and atrial pacing pulses being delivered in an alternating sequence to the ventricle and to the atrium, respectively.

11. A dual chamber antitachycardia pacing device according to claim 6, in combination with an implantable pacemaker cardioverter/defibrillator device, wherein said predetermined percentage comprises a first predetermined percentage, and wherein said analyzing means detects fibrillation when said cardiac output is less than a second predetermined percentage of said cardiac output standard, said second predetermined percentage being lower than said first predetermined percentage, and wherein said detecting means issues a defibrillation signal to said controlling means upon detection of said fibrillation.

12. A dual chamber antitachycardia pacing device according to claim 11, wherein said ultrasonic means is adapted to be implanted within the patient'"'"'s right heart for ensonifying the patient'"'"'s ascending aorta with ultrasonic energy and detecting returning ultrasonic energy reflected from blood cells within the ascending aorta.

13. A dual chamber antitachycardia pacing device according to claim 6, wherein said ultrasonic means is adapted to be implanted within the patient'"'"'s right heart for ensonifying the patient'"'"'s ascending aorta with ultrasonic energy and detecting returning ultrasonic energy reflected from blood cells within the ascending aorta.

14. A dual chamber antitachycardia pacing device according to claim 6, wherein said ultrasonic means includes an ultrasonic transmitting means utilizing timed bursts of ultrasonic pulses, and an ultrasonic receiving means employing Doppler measurement techniques, for monitoring said parameter.

15. A method of detecting and reverting cardiac arrhythmias in an antiarrhythmia pacing device comprising the steps of:

activating an ultrasonic sensor implanted within a patient'"'"'s cardiovascular system,

monitoring the output of said ultrasonic sensor to provide a cardiac output parameter corresponding to the volume of blood flow per unit of time within the cardiovascular system,

deriving a cardiac output standard based on a time history of said cardiac output parameters,

comparing said cardiac output parameter to said cardiac output standard,

detecting and classifying at least one pathological arrhythmia condition when said cardiac output parameter is less than at least one predetermined percentage of said cardiac output standard,

generating stimulation pulses for delivery within the patient'"'"'s heart, and

controlling the timing and sequence of said pulse stimulations to operate in an antiarrhythmia pacing mode corresponding to said classification.

16. A method of detecting and reverting cardiac arrhythmias according to claim 15, wherein said detecting step detects and classifies a pathological tachycardia condition and said controlling means controls said generating means to operate in an antitachycardia pacing mode.

17. A method of detecting and reverting cardiac arrhythmias according to claim 15, further comprising the steps of:

detecting fibrillation when said cardiac output parameter is less than a second predetermined percentage of said cardiac output standard, said second predetermined percentage being lower than said one predetermined percentage, and

performing at least one operation of cardioversion or defibrillation in response to said fibrillation detecting step.

18. A method of detecting and reverting cardiac arrhythmias according to claim 15, wherein said step of activating an ultrasonic transducer includes the further steps of:

transmitting timed bursts of pulses into the patient'"'"'s heart,

receiving ultrasonic echoes responding from said transmissions, and

analyzing said ultrasonic echoes using Doppler measurement techniques.

19. A method of detecting and reverting cardiac arrhythmias in a dual chamber antitachycardia pacing device comprising the steps of:

activating an ultrasonic sensor implanted within a patient'"'"'s cardiovascular system,

monitoring the output of said ultrasonic sensor to provide a cardiac output parameter corresponding to the volume of blood flow per unit of time within the cardiovascular system,

deriving a cardiac output standard based on a time history of said cardiac output parameters,

determining the patient'"'"'s heart rate,

comparing said cardiac output parameter to said cardiac output standard and comparing said heart rate to a predetermined heart rate boundary,

detecting a pathological arrhythmia when said cardiac output parameter is less than a predetermined percentage of said cardiac output standard and said heart rate is faster than said predetermined heart rate boundary,

generating stimulation pulses for delivery within the patient'"'"'s atrium and ventricle, and

controlling the timing and sequence of said atrial and ventricular pulse stimulations to operate in an antiarrhythmia pacing mode.

20. A method of detecting and reverting cardiac arrhythmias according to claim 19, further comprising:

operating in a dual chamber bradycardia pacing mode, having an interval between atrial heartbeats and ventricular stimulation pulses, when the patient'"'"'s heart is functioning with a below-normal natural rhythm,

initiating an A-V delay test operating submode of said dual chamber bradycardia pacing mode,

modulating the A-V delay between separate cardiac cycles following initiation of said A-V delay test operating submode,

associated respective ones of said monitored cardiac output parameters with their corresponding operating submode A-V delay values,

selecting an A-V delay associated with one of the largest cardiac output parameter based on said associating step, and

terminating said A-V delay test operating submode and resuming operation in said dual chamber bradycardia pacing mode utilizing said selected A-V delay as the interval between atrial heartbeats and ventricular stimulation pulses.

21. A method of detecting and reverting cardiac arrhythmias according to claim 20, wherein, said antiarrhythmia pacing mode is an antitachycardia pacing mode, and wherein atrial and ventricular pacing pulses are generated and delivered in a series of pulse trains with each train consisting of a plurality of pacing pulses and with said ventricular and atrial pacing pulses being delivered in an alternating sequence to the ventricle and to the atrium, respectively.

22. A method of detecting and reverting cardiac arrhythmias according to claim 21, wherein said atrial and ventricular pulses being delivered in said alternating sequence are spaced apart by said selected A-V delay interval.

23. A method of detecting and reverting cardiac arrhythmias according to claim 20 wherein said antiarrhythmia pacing mode includes the sub-steps of:

measuring the cycle length of the tachycardia,

determining a V-A interval value less than or equal to the tachycardia cycle length,

delivering a pulse to the ventricle,

determining an initial value of an A-V delay interval as a function of said selected A-V delay interval,

delivering a pulse to the atrium at the expiration of said determined V-A interval value,

delivering a pulse to the ventricle at the expiration of said A-V interval value,

repeating pulse delivery to the atrium and the ventricle until the expiration of N V-A intervals and N A-V intervals thereby completing a first train of pulses,

delivering a series of M trains of pulses similar to said first train of pulses, and

varying said A-V delay interval value from the initial value at least once prior to the completion of said series of M trains of pulses.

24. A method of detecting and reverting cardiac arrhythmias according to claim 19, wherein said antiarrhythmia pacing mode is an antitachycardia pacing mode, and wherein atrial and ventricular pacing pulses are generated and delivered in a series of pulse trains with each train consisting of a plurality of pacing pulses and with said ventricular and atrial pacing pulses being delivered in an alternating sequence to the ventricle and to the atrium, respectively.

25. A method of detecting and reverting cardiac arrhythmias according to claim 19, wherein said antiarrhythmia pacing mode is an antitachycardia pacing mode and includes the sub-steps of:

measuring the cycle length of the tachycardia,

determining a V-A interval value less than or equal to the tachycardia cycle length,

delivering a pulse to the ventricle,

determining an initial value of an A-V delay interval,

delivering a pulse to the atrium at the expiration of said determined V-A interval value,

delivering a pulse to the ventricle at the expiration of said A-V interval value,

repeating pulse delivery to the atrium and the ventricle until the expiration of N V-A intervals and N A-V intervals thereby completing a first train of pulses,

delivering a series of M trains of pulses similar to said first train of pulses, and

varying said A-V delay interval value from the initial value at least once prior to the completion of said series of M trains of pulses.

26. A method of detecting and reverting cardiac arrhythmias according to claim 19, wherein said predetermined percentage comprises a first predetermined percentage, and further comprising the steps of:

detecting fibrillation when said cardiac output is less than a second predetermined percentage of said cardiac output standard, said second predetermined percentage being lower than said first predetermined percentage, and

performing at least one operation of cardioversion or defibrillation in response to said detecting step.

27. A method of detecting and reverting cardiac arrhythmias according to claim 19, wherein said ultrasonic sensor is adapted to be implanted within the patient'"'"'s right heart, and wherein said step of activating an ultrasonic transducer includes the sub-steps of ensonifying the patient'"'"'s ascending aorta with ultrasonic energy, and detecting returning ultrasonic energy reflected from blood cells within the ascending aorta.

28. A method of detecting and reverting cardiac arrhythmias according to claim 19, wherein said step of activating an ultrasonic transducer includes the further steps of:

transmitting timed bursts of pulses into the patient'"'"'s heart,

receiving ultrasonic echoes responding from said transmissions, and

analyzing said ultrasonic echoes using Doppler measurement techniques.

29. An antiarrhythmia pacing device for the reversion of cardiac arrhythmias comprising:

means for generating stimulation pulses and adapted to deliver said pulses to a patient'"'"'s heart,

ultrasonic means adapted to be implanted within the patient'"'"'s right heart for ensonifying the patient'"'"'s ascending aorta with ultrasonic energy and detecting returning ultrasonic energy reflected from blood cells within the ascending aorta for monitoring a cardiac output parameter corresponding to the volume of blood flow per unit of time within the cardiovascular system,

means for deriving a cardiac output standard based on a time history of said cardiac output parameter,

means for comparing said cardiac output parameter to said cardiac output standard,

means responsive to said comparing means for detecting and classifying a pathological cardiac arrhythmia when said cardiac output parameter is less than at least one predetermined percentage of said cardiac output standard, and

means responsive to said detecting means for controlling said generating means to operate in an antiarrhythmia pacing mode corresponding to said classification.

30. An antiarrhythmia pacing device according to claim 29, wherein said detecting means detects and classifies a pathological tachycardia condition and said controlling means controls said generating means to operate in an antitachycardia pacing mode.

31. An antiarrhythmia pacing device according to claim 29, in combination with an implantable pacemaker carioverter/defibrillator device, wherein said classifying means classifies an arrhythmia as fibrillation when said cardiac output parameter is less than a second predetermined percentage of said cardiac output standard, said second predetermined percentage being lower than said one predetermined percentage, and wherein said detecting means issues a defibrillation signal to said controlling means upon detection of said fibrillation.

32. A method of detecting and reverting cardiac arrhythmias in an antiarrhythmia pacing device comprising the steps of:

activating an ultrasonic sensor implanted within a patient'"'"'s right heart, wherein said activating step includes the sub-steps of ensonifying the patient'"'"'s ascending aorta with ultrasonic energy, and detecting returning ultrasonic energy reflected from blood cells within the ascending aorta,

monitoring the output of said ultrasonic sensor to provide a cardiac output parameter corresponding to the volume of blood flow per unit of time within the cardiovascular system,

deriving a cardiac output standard based on a time history of said cardiac output parameters,

comparing said cardiac output parameter to said cardiac output standard,

detecting and classifying at least one pathological arrthythmia condition when said cardiac output parameter is less than at least one predetermined percentage of said cardiac output standard,

generating stimulation pulses for delivery within the patient'"'"'s heart, and

controlling the timing and sequence of said pulse stimulations to operate in an antiarrhythmia pacing mode corresponding to said classification.

33. A method of detecting and reverting cardiac arrhythmias according to claim 32, wherein said detecting step detects and classifies a pathological tachycardia condition and said controlling means controls said generating means to operate in an antitachycardia pacing mode.

34. A method of detecting and reverting cardiac arrhythmias according to claim 32, further comprising the steps of:

detecting fibrillation when said cardiac output parameter is less than a second predetermined percentage of said cardiac output standard, said second predetermined percentage being lower than said one predetermined percentage, and

performing at least one operation of cardioversion or defibrillation in response to said fibrillation detecting step.